Accéder directement au contenu

Elie Rassy

Medical oncologist and researcher; MD, MSc, MPH
6
Documents
Affiliations actuelles
  • 156104
  • 1051097

Présentation

Hematologist, oncologist and researcher with expertise in several tumor types, my main scope of interest encloses breast cancer and cancers of unknown primary. My profound dedication and experties have led to the publication of over 200 peer-reviewed articles and several book chapters. Notably, my contributions have been featured in prestigious publications such as the Oxford Textbook of Oncology, Nature Reviews Clinical Oncology, Lancet, JAMA Oncology, and others. I am actively engaged in promoting sustainability and advocating for the adoption of environmental, social, and governance (ESG) practices within the medical field. My commitment to driving major positive change further solidifies my reputation as a compassionate advocate for a better world. I’m currently a medical oncologist at Gustave Roussy and mainly involved in the Breast Cancer Unit where I have co-developed several trials and translational projects aimed at improving the diagnosis and treatment of breast cancer. Concurrently, I am finishing a PhD in public health at Paris Saclay - Center for Epidemiology and Public Health. Gustave Roussy has been named one of the world’s leading cancer-research institutes and the largest comprehensive cancer center in Europe. It ranks the third world’s best specialized hospitals in oncology 2023 according to Newsweek. Learn more about Gustave Roussy at https://www.gustaveroussy.fr/en and CESP at https://cesp.inserm.fr/en/agent/el-rassy

Domaines de recherche


Compétences

Operational & strategic experience Multinational & multicultural expertise Leadership and teambuilding abilities Excellent communication skills Extensive network & in-depth sector knowledge

Publications

Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials

Elie Rassy , Thomas Filleron , Alessandro Viansone , Magali Lacroix-Triki , Sofia Rivera
Breast Cancer Research and Treatment, 2023, 199 (2), pp.371-379. ⟨10.1007/s10549-023-06912-4⟩
Article dans une revue hal-04501568v1
Image document

The paradigm shift to precision oncology between political will and cultural acceptance

E. Rassy , J.-M. Heard , F. Andre
ESMO Open, 2023, 8 (5), pp.101622. ⟨10.1016/j.esmoop.2023.101622⟩
Article dans une revue inserm-04521235v1
Image document

Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies.

Yuedan Zhou , Elie Rassy , Alexandre Coutte , Samir Achkar , Sophie Espenel
Cancers, 2022, 14 (10), ⟨10.3390/cancers14102449⟩
Article dans une revue hal-03686656v1
Image document

The role of site-specific therapy for cancers of unknown of primary: A meta-analysis

Elie Rassy , Ziad Bakouny , Toni K. Choueiri , Eliezer M. van Allen , Karim Fizazi
European Journal of Cancer, 2020, 127, pp.118 - 122. ⟨10.1016/j.ejca.2019.12.016⟩
Article dans une revue hal-03489893v1
Image document

A comprehensive overview of promising biomarkers in stage II colorectal cancer

Pauline Parent , Romain Cohen , Elie Rassy , Magali Svrcek , Julien Taieb
Cancer Treatment Reviews, 2020, 88, pp.102059 -. ⟨10.1016/j.ctrv.2020.102059⟩
Article dans une revue hal-03492180v1
Image document

The currently declining incidence of cancer of unknown primary

Elie Rassy , Nicholas Pavlidis
Cancer Epidemiology, 2019, 61, pp.139 - 141. ⟨10.1016/j.canep.2019.06.006⟩
Article dans une revue hal-03485854v1